REGN

REGENERON PHARMACEUTICALS INC

Healthcare | Large Cap

$15.37

EPS Forecast

$4,668

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

$15.37

Revenue Forecast:

$4,668

EPS Surprise Forecast:

$1.613

Revenue Surprise Forecast:

$118

Post-release price volatility - Medium

Post-release Overnight Move:

±5.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

96%

Probability of beating revenue consensus:

86%

Probability of beating both EPS & revs consensus:

84%

Probability of missing both EPS & revs consensus:

2%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

2

Beta (β)

Forward Looking Beta (β):

0.80

Earnings volatility

EPS standard deviation:

$1.57

Revenue standard deviation:

$175

As % of share price:

0.21% MEDIUM

As % of market cap:

0.23% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$17.72

Revenue 95th %ile:

$4,945

EPS 75th %ile:

$15.98

Revenue 75th %ile:

$4,746

EPS 25th %ile:

$14.98

Revenue 25th %ile:

$4,602

EPS 5th %ile:

$13.97

Revenue 5th %ile:

$4,448

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

47% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

43% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$12

Bid-ask per Share:

$0.9